Drug Pricing Reform Must Be A Priority For Congress

FOR IMMEDIATE RELEASE
JUNE 22, 2021

Drug Pricing Reform Must Be A Priority For Congress

“Americans cannot spend another day rationing their medications because they have been priced out of reach by profit-hungry Big Pharma.”

WASHINGTON, DC — Yesterday, Senate Finance Committee Chair Ron Wyden (D-OR) released new principles for drug pricing that would help lower the cost of life-saving medications. Chairman Wyden’s proposals are common-sense and extremely popular. One of his proposals includes expanding Medicare’s power to negotiate drug prices directly with pharmaceutical companies — a measure that Health Care Voter has consistently called on Congress to implement. Another proposal calls for restructuring Medicare Part D to lower out-of-pocket costs for seniors.

Health Care Voter Co-Chair Laura Packard gave the following statement:

“The high cost of prescription drugs force too many Americans deeper and deeper into debt, or to suffer without the care we need. These proposals from Chairman Wyden are highly popular across the ideological spectrum, and they should have support on both sides of the aisle. Lawmakers must do everything in their power to swiftly pass these drug pricing reforms. Americans cannot spend another day rationing their medications because they have been priced out of reach by profit-hungry Big Pharma. Our lives are at stake—we literally can’t afford to wait any longer.”

###